Objective Prevalence rates of depression and anxiety in patients with Multiple Sclerosis
(MS) vary widely across studies. Aim of this systematic review and meta-analysis was to a) …

Depression—be it a formal diagnosis based on consensus clinical criteria, or a collection of
symptoms revealed by a self-report rating scale—is common in patients with multiple …

Depressive disorders occur in up to 50% of people living with multiple sclerosis (MS).
Prevalence estimates are generally 2–3-times higher than those of the general population …

Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS).
Objective: The objective of this review is to estimate the incidence and prevalence of …

Several studies have reported high rates of depression in multiple sclerosis (MS) with a
lifetime prevalence of∼ 50% and an annual prevalence of 20% not uncommon. Concern …

Clinically significant depression can affect up to 50% of patients with multiple sclerosis over
the course of their lifetime. It is associated with an increased morbidity and mortality and is …

Depressive disorders are common in patients with multiple sclerosis, influencing their quality
of life and adherence to treatments, as well as becoming more frequent with the progression …

Substantial evidence demonstrates that inflammatory processes may underlie depression
for a subset of patients, including work showing that healthy subjects exposed to an …

Multiple sclerosis (MS) is a chronic, progressive disease of the central nervous system that is
characterised by inflammatory damage to the myelin sheath. Though often neglected …

Objective: The coronavirus disease 2019 (COVID-19) has radically changed the world in a
few weeks. Italy has been one of the first and most affected countries with more than 30,000 …